drugset / Trial / NCT02078661
Safety and Efficacy of PG101 for Dry Eye Syndrome
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the safety and efficacy of 0.25% PG101 and 1.0% PG101 topical gel suspension compared to placebo when administered two times daily for 14 days in subjects diagnosed with dry eye syndrome
Timeline
- Start
- 2013-12
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | PG101 | Unknown | 0.25 % | — |
| Comparator | PG101 | Unknown | 1 % | — |